Parabolic Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep' 20	Jun' 20	Mar' 20	Jun' 19	Mar' 19

Sales

-

-

-

-

-

Operating profit

-

-1.71

-1.71

-1.95

-1.97

Interest

-

0.17

0.17

0.16

-0.54

Gross profit

-0.01

-1.88

-1.88

-2.10

-1.42

EPS (Rs)

-0.01

-1.17

-1.17

-1.21

-1.41

Other income

-

-

-

0.01

0.01

Stock adjustment

-

-

-

-

0.59

Raw material

-

-

-

-

-0.27

Power and fuel

-

-

-

-

-

Employee expenses

-

0.42

0.42

1.09

1.34

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

-

1.29

1.29

0.86

0.31

Provisions made

-

-

-

-

-

Depreciation

0.05

5.34

5.34

5.56

5.22

Taxation

-

-

-

-0.17

0.18

Net profit / loss

-0.05

-7.22

-7.22

-7.49

-8.70

Extra ordinary item

-

-

-

-

-1.88

Prior year adjustments

-

-

-

-

-

Equity capital

61.89

61.89

61.89

61.89

61.89

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-

-

-

-

-

GPM (%)

-

-

-

-

-

NPM (%)

-

-

-

-

-